Bifogade filer
Kurs
-3,39%
Likviditet
0,68 MSEK
Prenumeration
Kalender
Est. tid* | ||
2025-11-13 | 08:00 | Kvartalsrapport 2025-Q3 |
2025-08-21 | - | Kvartalsrapport 2025-Q2 |
2025-05-07 | - | X-dag ordinarie utdelning IMMU 0.00 SEK |
2025-05-06 | - | Årsstämma |
2025-05-06 | - | Kvartalsrapport 2025-Q1 |
2025-02-13 | - | Bokslutskommuniké 2024 |
2024-11-08 | - | Kvartalsrapport 2024-Q3 |
2024-08-23 | - | Kvartalsrapport 2024-Q2 |
2024-06-03 | - | Split IMMU 20:1 |
2024-05-20 | - | X-dag ordinarie utdelning IMMU 0.00 SEK |
2024-05-17 | - | Årsstämma |
2024-05-17 | - | Kvartalsrapport 2024-Q1 |
2024-02-14 | - | Bokslutskommuniké 2023 |
2023-12-13 | - | Extra Bolagsstämma 2023 |
2023-11-09 | - | Kvartalsrapport 2023-Q3 |
2023-08-29 | - | Kvartalsrapport 2023-Q2 |
2023-05-15 | - | X-dag ordinarie utdelning IMMU 0.00 SEK |
2023-05-12 | - | Årsstämma |
2023-05-12 | - | Kvartalsrapport 2023-Q1 |
2023-02-17 | - | Bokslutskommuniké 2022 |
2022-11-18 | - | Extra Bolagsstämma 2022 |
2022-11-11 | - | Kvartalsrapport 2022-Q3 |
2022-08-26 | - | Kvartalsrapport 2022-Q2 |
2022-05-11 | - | X-dag ordinarie utdelning IMMU 0.00 SEK |
2022-05-10 | - | Årsstämma |
2022-05-10 | - | Kvartalsrapport 2022-Q1 |
2022-02-17 | - | Bokslutskommuniké 2021 |
2021-10-28 | - | Kvartalsrapport 2021-Q3 |
2021-08-26 | - | Kvartalsrapport 2021-Q2 |
2021-05-05 | - | X-dag ordinarie utdelning IMMU 0.00 SEK |
2021-05-04 | - | Årsstämma |
2021-05-04 | - | Kvartalsrapport 2021-Q1 |
2021-02-18 | - | Bokslutskommuniké 2020 |
2021-01-22 | - | Extra Bolagsstämma 2021 |
2020-12-18 | - | Extra Bolagsstämma 2020 |
2020-11-05 | - | Kvartalsrapport 2020-Q3 |
2020-08-27 | - | Kvartalsrapport 2020-Q2 |
2020-04-29 | - | X-dag ordinarie utdelning IMMU 0.00 SEK |
2020-04-28 | - | Årsstämma |
2020-04-28 | - | Kvartalsrapport 2020-Q1 |
2020-02-18 | - | Bokslutskommuniké 2019 |
2019-11-06 | - | Kvartalsrapport 2019-Q3 |
2019-08-20 | - | Kvartalsrapport 2019-Q2 |
2019-04-26 | - | X-dag ordinarie utdelning IMMU 0.00 SEK |
2019-04-25 | - | Årsstämma |
2019-04-25 | - | Kvartalsrapport 2019-Q1 |
2019-02-15 | - | Bokslutskommuniké 2018 |
2018-11-07 | - | Kvartalsrapport 2018-Q3 |
2018-08-17 | - | Kvartalsrapport 2018-Q2 |
2018-05-04 | - | Kvartalsrapport 2018-Q1 |
2018-04-26 | - | X-dag ordinarie utdelning IMMU 0.00 SEK |
2018-04-25 | - | Årsstämma |
2018-02-16 | - | Bokslutskommuniké 2017 |
2017-12-04 | - | Extra Bolagsstämma 2017 |
2017-11-17 | - | Kvartalsrapport 2017-Q3 |
2017-08-18 | - | Kvartalsrapport 2017-Q2 |
2017-05-19 | - | Kvartalsrapport 2017-Q1 |
2017-04-27 | - | X-dag ordinarie utdelning IMMU 0.00 SEK |
2017-04-26 | - | Årsstämma |
2017-02-17 | - | Bokslutskommuniké 2016 |
2016-05-20 | - | Kvartalsrapport 2016-Q3 |
2016-02-19 | - | Kvartalsrapport 2016-Q2 |
2015-12-03 | - | Årsstämma |
2015-09-18 | - | Bokslutskommuniké 2015 |
2015-05-21 | - | Kvartalsrapport 2015-Q3 |
2015-02-20 | - | Kvartalsrapport 2015-Q2 |
2014-12-04 | - | X-dag ordinarie utdelning IMMU 0.00 SEK |
2014-12-03 | - | Årsstämma |
2014-11-18 | - | Kvartalsrapport 2015-Q1 |
2014-09-17 | - | Bokslutskommuniké 2014 |
2014-05-07 | - | Kvartalsrapport 2014-Q3 |
2014-02-18 | - | Kvartalsrapport 2014-Q2 |
2013-12-04 | - | X-dag ordinarie utdelning IMMU 0.00 SEK |
2013-12-03 | - | Årsstämma |
2013-12-03 | - | Kvartalsrapport 2014-Q1 |
2013-09-10 | - | Bokslutskommuniké 2013 |
Beskrivning
Land | Sverige |
---|---|
Lista | Small Cap Stockholm |
Sektor | Hälsovård |
Industri | Bioteknik |
The board of directors of Mendus AB (publ) ("Mendus") has decided, based on the authorization from the Annual General Meeting on 6 May 2025, to transfer own shares on Nasdaq Stockholm.
In order to give Mendus the possibility to sell own shares to preserve cash with respect to payment in cash to the employees and board members that have chosen to receive their bonus and remuneration, respectively, paid in cash as well as hedge payments of taxes and other costs related to the payment of the bonus and remuneration, the Annual General Meeting on May 6, 2025 resolved to authorize the board of directors, at one or more occasions during the period until the next Annual General Meeting, to transfer own shares on Nasdaq Stockholm.
Based on the authorization from the Annual General Meeting on 6 May 2025, the board of directors has decided to transfer up to 1,200,000 own shares at Nasdaq Stockholm. The shares will be transferred during the period 21 August 2025 – 30 April 2026 at a price per share within the registered price interval at any given time. No sales will take place during 30 days prior to the publication of a financial report. The transfer of shares will be executed discretionary by DNB Bank ASA and will be reported via Nasdaq Stockholm in accordance with applicable rules.
At the time of this press release, there are 52,084,578 shares in Mendus, all which are ordinary shares. At the time of this press release, Mendus holds 1,350,549 shares.
For more information, please contact:
Erik Manting
Chief Executive Officer
E-mail: ir@mendus.com
About Mendus AB (publ)
Mendus is dedicated to changing the course of cancer treatment by addressing tumor recurrence and improving long-term survival for cancer patients, while preserving health and quality of life. We leverage our understanding of dendritic cell biology to develop an advanced clinical pipeline of immunotherapies which combine clinical efficacy with a benign safety profile. Based in Sweden and The Netherlands, Mendus is publicly traded on the Nasdaq Stockholm under the ticker IMMU.ST. https://www.mendus.com/
Attachments
Mendus transfer of shares